MiMedx Announces Resignation of Board Member
Dr.
Mr. Aguilar noted, "After a difficult period, I believe the Company is well situated to refocus itself on industry leadership through product and pipeline innovation. It is gratifying to have been part of this effort to reorient the Company toward the future. I am confident that the Company is well positioned to serve the interests of its shareholders, patients and employees."
About
MiMedx® is an industry leader in advanced wound care and an emerging therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization.
Contact:
Corporate & Investor Communications
770.651.9066
investorrelations@mimedx.com
View original content:http://www.prnewswire.com/news-releases/mimedx-announces-resignation-of-board-member-300922657.html
SOURCE